收藏本站    您好,欢迎光临上海懋康生物科技有限公司!
登录  |   注册
当前位置: 首页> 产品中心> 信号转导研究相关 > CGPCRs/G Protein > Semaglutide 索马鲁肽(促销中)
Semaglutide 索马鲁肽(促销中)
目录号 MZ7352-10MG 售价 5980.00元
规格 10mg 运输温度 冰袋运输。
其他名称 保存温度 2-8℃密封干燥短期保存,长期置于-20℃密封干燥保存,至少2年有效。
CAS号 910463-68-2 有效期
应用 订购数量
产品简介:

Semaglutide 索马鲁肽



产品关键词:

Semaglutide 索马鲁肽;Liraglutide利拉鲁肽; GLP-1受体激动剂;Metformin HCl盐酸二甲双胍;Acarbose阿卡波糖;Antidiabetic drug抗糖尿病药物;Streptozotocin (STZ)链脲佐菌素;CAS:910463-68-2;


产品信息

产品名称

产品编号

CAS NO.

规格

价格(元)

促销价(元)

Semaglutide索马鲁肽

MZ7352-1MG

910463-68-2

1mg

1580

1422

Semaglutide索马鲁肽

MZ7352-5MG

910463-68-2

5mg

3980

3582

Semaglutide索马鲁肽

MZ7352-10MG

910463-68-2

10mg

5980

5382

【温馨提示】:见我司(MKBio)的小分子化合物常见问题-懋康生物

【温馨提示】:见我司(MKBio)整理的糖尿病模型建立-链脲佐菌素(STZ)。


产品描述

索马鲁肽(Semaglutide)是一种胰高血糖素样肽-1(GLP-1) 受体激动剂,在表达人受体的BHK细胞报告基因实验中,EC50=6.2 pM。在db/db小鼠的II型糖尿病中,索马鲁肽可降低血糖水平,以葡萄糖依赖的方式刺激胰岛素和抑制胰高血糖素分泌。索马鲁肽是比利拉鲁肽(Liraglutide, MZ7351)更长效的替代物,结构上类似于GLP-1。在MPTP诱导的帕金森模型中,索马鲁肽(25 nmol/kg)预防塞梅林氏神经节中多巴胺能神经元的减少,提高塞梅林氏神经节和纹状体中的脂质过氧化,以及改善滚轴实验和足迹分析中动物的运动协调。索马鲁肽具抗肥胖活性。减低能量摄取,索马鲁肽诱导的体重减轻可能的作用机制包括:食欲降低,更好的控制饮食和相对来说更低程度的嗜好脂肪和热量较重的食物。


产品特性

1) CAS NO:910463-68-2

2) 序列:H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala- Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH

3) 同义名:Semaglutide free acid; NN 9535; NNC 0113-0217; Ozempic

4) 分子式:C187H291N45O59

5) 分子量:4113.58

6) 纯度:≥98%

7) 外观:白色粉末

8) 溶解性:溶于DMSO(3mg/ml)、不溶于乙醇和水


保存与运输方法

保存:2-8℃密封干燥短期保存,长期置于-20℃密封干燥保存,至少2年有效。 

运输:冰袋运输。


注意事项

1) 针对溶解性比较差的化合物,可通过≤60℃温育和(或)超声的方式来促进其溶解。不同批次化合物的溶解性会有差异,以实际测定为准。

2) 本品配制的储存液请尽快使用,若单次不能用完,请根据单次用量分装,≤-20℃保存(-20℃ 一个月;-80℃ 六个月)。

3) 本品并非商业化的临床药物,仅用作科研用途,不得用作临床诊断或治疗,不得用于食品或药品,绝对禁止用在人身上。  

4) 为了您的安全和健康,请穿实验服并戴一次性手套操作。


配制储存液

          质量

溶剂体积

浓度

1mg

5mg

10mg

0.5mM

0.4862 mL

2.4310 mL

4.8619 mL

0.1mM

2.4310 mL

12.1549 mL

24.3097mL


使用方法【源自文献,仅作参考】

文献1,Rakipovski G, Rolin B, Nøhr J, Klewe I, Frederiksen KS, Augustin R, Hecksher-Sørensen J, Ingvorsen C, Polex-Wolf J, Knudsen LB. The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE-/- and LDLr-/- Mice by a Mechanism That Includes Inflammatory Pathways. JACC Basic Transl Sci. 2018 Nov 21;3(6):844-857. doi: 10.1016/j.jacbts.2018.09.004. PMID: 30623143; PMCID: PMC6314963.


体内研究(动物模型):

动物模型(Animal Model):C57BL/6J lean male mice at 12 weeks of age

实验方法(Assay):To studyacute inflammation in vivo study design, C57BL/6J lean male mice at 12 weeks of age were givenSC doses of semaglutide (60.0 μg/kg) or vehicle control 1 hour prior to receiving an IP dose of lipopolysaccharide (LPS) (0.05 mg/kg, Escherichia coli O55:B5) or vehicle control.Blood samples were collected from the sinus orbital vein at 1 and 4 h after LPS dose.

文献2,Wang L, Ding J, Zhu C, Guo B, Yang W, He W, Li X, Wang Y, Li W, Wang F, Wang F, et al: Semaglutide attenuates seizure severity and ameliorates cognitive dysfunction by blocking the NLR family pyrin domain containing 3 inflammasome in pentylenetetrazole‑kindled mice. Int J Mol Med 48: 219, 2021


体外研究:

细胞类型(Cell type):BV2 cells

实验方法(Assay): BV2 cells were seeded into 96-well plates (1×104 cells/well) for 12 h, and thentreated with different doses (300, 600, 900 or 1,000 nM) of semaglutide for 20 h at 37°C. A blank well with culture medium was used to detect background, and five replicate wells were established per group. CCK-8 reagent (100 µl) was added toevaluate cellular proliferation.


体内研究(动物模型):

动物模型(Animal Model):C57BL/6J mice (male, 10±2 weeks old; weight, 25±3 g)

实验方法(Assay):The animals were randomized into five groups (20 per group), all of which were treated by intraperitoneal (i.p.) injection. In the control group (1% DMSO, i.p.), mice received 20 injections in total - 19 injections every other day for 37 days, and a final injection on the 45th day.For the semaglutide group [25 nM/kg semaglutide i.p.], the administration schedule was the same as that for the control group. In the PTZ group [37 mg/kg PTZ, i.p.], the mice received a total of 16 injections - one injection every other day from the 9th to the 37th day for a total of 15 injections, and a final injection on the 45th day.For the low-dose semaglutide group [37 mg/kg PTZ + 10 nM/kg semaglutide, i.p.], the semaglutide administration schedule was the same as that for the control group, and the PTZ administration schedule was the same as that for the PTZ group, 30 min after each injection of semaglutide.For the high-dose semaglutide group (37 mg/kg PTZ + 25 nM/kg semaglutide, i.p.), the administration schedule was the same as that for the low-dose semaglutide group.

相关产品

货号

名称

规格

MZ7351-1MG

Liraglutide利拉鲁肽

1mg

MZ7352-1MG

Semaglutide索马鲁肽

1mg

MZ3403-1G

Metformin Hydrochloride盐酸二甲双胍

1g

MZ99023-1G

Acarbose阿卡波糖

1g

MS1601-100MG

Streptozotocin (STZ)链脲佐菌素

100mg

 

 

 — —Written/Edited by V. Shallan【版权归MKBio懋康所有】

 

 

上海懋康生物科技有限公司是一家涉足于生命科学和生物技术领域研究的试剂、仪器和实验室消耗品与实验服务工作,主要从事细胞生物学、植物学、分子生物学、免疫学、生物化学、蛋白组学。生物制药与诊断试剂研发生产等领域。 本公司秉承“以人为本,以诚为信、合同守信”的经营理念。坚持"品质保障"的原则为广大客户提供优质产品。

K
电话:021-54736159    传真:021-54736159    手机:18121428569
邮箱: sales@maokangbio.com
地址:上海市徐汇区龙吴路2888弄23号902室    
版权所有:上海懋康生物科技有限公司